4.3 Article

Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4α on hepatocellular carcinoma

Journal

ONCOTARGET
Volume 7, Issue 19, Pages 27408-27421

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.8478

Keywords

apoptosis signal-regulating kinase 1; hepatocyte nuclear factor 4 alpha; hepatocellular carcinoma; mitogen-activated protein kinases; differentiation therapy

Funding

  1. National Natural Science Foundation of China [81270033, 81230011]
  2. National Natural Science Foundation of China (Creative Research Groups) [81521091]
  3. Foundation for the Author of National Excellent Doctoral Dissertation of China [201477]

Ask authors/readers for more resources

Previous studies provided substantial evidence of a striking suppressive effect of hepatocyte nuclear factor 4 alpha (HNF4 alpha) on hepatocellular carcinoma (HCC). Apoptosis signal-regulating kinase 1 (ASK1) is involved in death receptor-mediated apoptosis and may acts as a tumor suppressor in hepatocarcinogenesis. However, the status and function of ASK1 during HCC progression are unclear. In this study, we found that HNF4 alpha increased ASK1 expression by directly binding to its promoter. ASK1 expression was dramatically suppressed and correlated with HNF4 alpha levels in HCC tissues. Reduced ASK1 expression was associated with aggressive tumors and poor prognosis for human HCC. Moreover, ASK1 inhibited the malignant phenotype of HCC cells in vitro. Intratumoral ASK1 injection significantly suppressed the growth of subcutaneous HCC xenografts in nude mice. More interestingly, systemic ASK1 delivery strikingly inhibited the growth of orthotopic HCC nodules in NOD/SCID mice. In addition, inhibition of endogenous ASK1 partially reversed the suppressive effects of HNF4 alpha on HCC. Collectively, this study highlights the suppressive effect of ASK1 on HCC and its biological significance in HCC development. These outcomes broaden the knowledge of ASK1 function in HCC progression, and provide a novel potential prognostic biomarker and therapeutic target for advanced HCC.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available